MedPath

Vadimezan

Generic Name
Vadimezan
Drug Type
Small Molecule
Chemical Formula
C17H14O4
CAS Number
117570-53-3
Unique Ingredient Identifier
0829J8133H

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in solid tumors, lung cancer, ovarian cancer, and prostate cancer.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath